Bunkerhill Health vs Hyperfine Swoop

Bunkerhill sells an AI agent platform to health systems, with nine cleared imaging algorithms alongside and osteoporosis detection from prior CTs as one use case. Hyperfine sells a magnet. These are different purchases, so each gets its own buyer. Bunkerhill fits a health system with an enterprise budget and a demo-led procurement, since pricing is quote only. Swoop fits an ICU or neurology unit that cannot move a patient to a fixed scanner or has no shielded room to build. It images the brain at 0.064T with T1, T2, FLAIR and diffusion sequences, and Hyperfine holds 17 FDA records. A neuroradiology group that needs contrast-enhanced T1 or fine anatomical detail keeps its conventional scanner, since the low-field papers describe lower resolution and no contrast-enhanced T1. Hyperfine lists no price. Its FY2025 10-K describes ownership plus an annual service agreement on 36- or 60-month terms. An older Scientific Reports paper estimated about $50,000 per system, and the 10-K puts the average conventional MRI near $1.2 million. Hyperfine reported a Q2 2026 net loss of $9.3 million, per a Yahoo Finance summary.